Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Seres Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Seres Therapeutics

Seres Therapeutics

Public

Seres Therapeutics, a US-based company, develops biological drugs to restore health by repairing dysbiotic microbiomes.

HQ
Cambridge, MA, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Seres Therapeutics, founded in Cambridge, United States, is dedicated to transforming patient lives through revolutionary microbiome therapeutics. The company's core mission is to develop biological drugs that restore health by repairing dysbiotic microbiomes. Seres Therapeutics focuses on creating treatments for various conditions, including metabolic diseases, leveraging their advanced microbiome therapeutics platform to address unmet medical needs.

Notable affiliated individuals include key researchers and industry experts who have significantly contributed to the company's innovative approach. Seres Therapeutics has attracted substantial investment from prominent venture capital firms and strategic partners. The company has achieved significant milestones, including advancing several therapeutic candidates into clinical trials and demonstrating promising results in restoring microbiome health. Their impact is evident in their potential to revolutionize treatment paradigms for numerous diseases, offering new hope to patients worldwide.

Seres Therapeutics - Similar Companies

Microbiome Therapeutics logo

Microbiome Therapeutics

Petri Bio logo

Petri Bio

petribio.com

Solarea Bio logo

Solarea Bio

solareabio.com

DermBiont logo

DermBiont

dermbiont.com

Naked Biome logo

Naked Biome

MarvelBiome logo

MarvelBiome

marvelbiome.com

Serenus Biotherapeutics logo

Serenus Biotherapeutics

MatriSys Bioscience logo

MatriSys Bioscience

matrisysbio.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Holobiome logo

Holobiome

holobiome.org

Vedanta Biosciences logo

Vedanta Biosciences

vedantabio.com

Persephone Biosciences logo

Persephone Biosciences

Seed Health logo

Seed Health

seedhealth.com

Aobiome logo

Aobiome

aobiome.com

Fortis Biosciences logo

Fortis Biosciences

Seres Therapeutics - Quick Facts

Who are Seres Therapeutics' competitors?

Companies similar to Seres Therapeutics include Microbiome Therapeutics, Petri Bio, Solarea Bio and DermBiont.

When was Seres Therapeutics founded?

Seres Therapeutics was founded in 2010.

Where is Seres Therapeutics' headquarters located?

Seres Therapeutics' headquarters is located in Cambridge, MA, US.

When was Seres Therapeutics' last funding round?

Seres Therapeutics' most recent funding round was for $110M (USD) in April 2023.

How much has Seres Therapeutics raised to-date?

As of Apr 27, 2023, Seres Therapeutics has raised a total of $537.8M (USD).

How many employees does Seres Therapeutics have?

Seres Therapeutics has 431 employees as of Feb 6, 2024.

Seres Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biological Drugs
Tags
  • Biotech
Unique IDs
  • ein: 274326290
  • secCik: 0001609809
  • ticker: MCRB
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research